These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24448453)

  • 21. Are innovation and new technologies in precision medicine paving a new era in patients centric care?
    Seyhan AA; Carini C
    J Transl Med; 2019 Apr; 17(1):114. PubMed ID: 30953518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precision Medicine With Point-of-Care Ultrasound: The Future of Personalized Pediatric Emergency Care.
    Kessler D; Ng L; Tessaro M; Fischer J
    Pediatr Emerg Care; 2017 Mar; 33(3):206-209. PubMed ID: 28248760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
    Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
    Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innovation, productivity, and pricing: Capturing value from precision medicine technology in Canada.
    Emery JCH; Zwicker JD
    Healthc Manage Forum; 2017 Jul; 30(4):197-199. PubMed ID: 28929867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.
    Trosman JR; Weldon CB; Douglas MP; Deverka PA; Watkins JB; Phillips KA
    Value Health; 2017 Jan; 20(1):40-46. PubMed ID: 28212967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular insights provide the critical path to disease mitigation.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2014 Jan; 95(1):3-7. PubMed ID: 24352148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precision Medicine: From Science To Value.
    Ginsburg GS; Phillips KA
    Health Aff (Millwood); 2018 May; 37(5):694-701. PubMed ID: 29733705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The University of New Mexico Center for Molecular Discovery.
    Edwards BS; Gouveia K; Oprea TI; Sklar LA
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):256-65. PubMed ID: 24409953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Going MAD: development of a "matrix academic division" to facilitate translating research to personalized medicine.
    Whitcomb DC
    Acad Med; 2011 Nov; 86(11):1353-9. PubMed ID: 21952059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personalized reproductive medicine on the brink: progress, opportunities and challenges ahead.
    Beim PY; Elashoff M; Hu-Seliger TT
    Reprod Biomed Online; 2013 Dec; 27(6):611-23. PubMed ID: 24449934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Machine Learning Applications to Accelerate Personalized Medicine in Breast Cancer: Rise of the Support Vector Machines.
    Ozer ME; Sarica PO; Arga KY
    OMICS; 2020 May; 24(5):241-246. PubMed ID: 32228365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
    O'Donnell JC
    Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One mouse, one patient paradigm: New avatars of personalized cancer therapy.
    Malaney P; Nicosia SV; Davé V
    Cancer Lett; 2014 Mar; 344(1):1-12. PubMed ID: 24157811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized medicine: motivation, challenges, and progress.
    Goetz LH; Schork NJ
    Fertil Steril; 2018 Jun; 109(6):952-963. PubMed ID: 29935653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticals.
    Govender R; Abrahmsén-Alami S; Larsson A; Folestad S
    Eur J Pharm Biopharm; 2020 Apr; 149():58-76. PubMed ID: 31982577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.
    Faulkner E; Annemans L; Garrison L; Helfand M; Holtorf AP; Hornberger J; Hughes D; Li T; Malone D; Payne K; Siebert U; Towse A; Veenstra D; Watkins J;
    Value Health; 2012 Dec; 15(8):1162-71. PubMed ID: 23244820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach.
    Zhang A; Sun H; Wang P; Han Y; Wang X
    Complement Ther Med; 2012; 20(1-2):93-9. PubMed ID: 22305254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collaboration as a foundation for advancing research in personalized medicine in cancer care.
    Krasna MJ
    Per Med; 2010 Nov; 7(6):669-675. PubMed ID: 29788564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artificial intelligence in medicine and cardiac imaging: harnessing big data and advanced computing to provide personalized medical diagnosis and treatment.
    Dilsizian SE; Siegel EL
    Curr Cardiol Rep; 2014 Jan; 16(1):441. PubMed ID: 24338557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.